Concepts (74)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Ketoacidosis | 1 | 2021 | 12 | 0.750 |
Why?
|
| Wounds, Penetrating | 1 | 2016 | 24 | 0.540 |
Why?
|
| Unnecessary Procedures | 1 | 2016 | 42 | 0.540 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 537 | 0.520 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2016 | 103 | 0.500 |
Why?
|
| Trauma Centers | 1 | 2016 | 119 | 0.500 |
Why?
|
| Poisoning | 1 | 2012 | 29 | 0.390 |
Why?
|
| Organ Dysfunction Scores | 2 | 2021 | 18 | 0.360 |
Why?
|
| Neurology | 1 | 2011 | 35 | 0.360 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 105 | 0.330 |
Why?
|
| Heart Arrest | 2 | 2024 | 161 | 0.320 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 1481 | 0.320 |
Why?
|
| Emergency Medical Services | 1 | 2011 | 251 | 0.290 |
Why?
|
| Referral and Consultation | 1 | 2011 | 409 | 0.290 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2011 | 454 | 0.270 |
Why?
|
| Critical Illness | 2 | 2021 | 341 | 0.260 |
Why?
|
| Sepsis | 2 | 2020 | 282 | 0.250 |
Why?
|
| Retrospective Studies | 5 | 2021 | 6136 | 0.240 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2024 | 85 | 0.200 |
Why?
|
| APACHE | 1 | 2021 | 52 | 0.190 |
Why?
|
| Adult | 6 | 2021 | 15981 | 0.180 |
Why?
|
| Intensive Care Units | 2 | 2021 | 454 | 0.170 |
Why?
|
| Prognosis | 2 | 2021 | 1591 | 0.170 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 64 | 0.150 |
Why?
|
| Resuscitation | 1 | 2019 | 71 | 0.150 |
Why?
|
| False Negative Reactions | 1 | 2016 | 40 | 0.140 |
Why?
|
| Radiation Exposure | 1 | 2016 | 16 | 0.140 |
Why?
|
| Adolescent | 2 | 2021 | 5956 | 0.130 |
Why?
|
| Injury Severity Score | 1 | 2016 | 102 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1470 | 0.130 |
Why?
|
| Humans | 10 | 2024 | 60093 | 0.110 |
Why?
|
| Patient Selection | 1 | 2016 | 453 | 0.110 |
Why?
|
| Collagen Type I | 1 | 2013 | 38 | 0.100 |
Why?
|
| Prevalence | 1 | 2016 | 1295 | 0.100 |
Why?
|
| Poison Control Centers | 1 | 2012 | 6 | 0.100 |
Why?
|
| Middle Aged | 3 | 2016 | 16539 | 0.100 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 153 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 239 | 0.090 |
Why?
|
| Female | 4 | 2020 | 31223 | 0.080 |
Why?
|
| NFATC Transcription Factors | 1 | 2009 | 20 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 41 | 0.080 |
Why?
|
| Aged | 3 | 2020 | 13575 | 0.080 |
Why?
|
| Male | 3 | 2016 | 27959 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2012 | 1311 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 187 | 0.070 |
Why?
|
| Infant | 1 | 2012 | 1531 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2012 | 1849 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2011 | 524 | 0.070 |
Why?
|
| Young Adult | 1 | 2016 | 4392 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2013 | 2892 | 0.050 |
Why?
|
| Child | 1 | 2012 | 4331 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 5192 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 1132 | 0.040 |
Why?
|
| Epinephrine | 1 | 2019 | 42 | 0.040 |
Why?
|
| Pandemics | 1 | 2024 | 629 | 0.040 |
Why?
|
| Coronary Circulation | 1 | 2019 | 50 | 0.040 |
Why?
|
| Calcitonin | 1 | 2019 | 17 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 1383 | 0.030 |
Why?
|
| Fibronectins | 1 | 2013 | 41 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2013 | 91 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 168 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 184 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 594 | 0.020 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 2009 | 2 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2009 | 36 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 26 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2009 | 96 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 124 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1040 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 646 | 0.020 |
Why?
|
| Cell Survival | 1 | 2009 | 558 | 0.020 |
Why?
|
| Cell Movement | 1 | 2009 | 426 | 0.020 |
Why?
|
| Mice | 1 | 2009 | 10331 | 0.010 |
Why?
|
| Animals | 1 | 2009 | 19749 | 0.010 |
Why?
|